InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IMPACT BIOMEDICAL INC.

IBO Clue Score29
United States Fiscal year ends December CIK 0001834105
$4.03 -5.18% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.03 +560.66% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 16 Sep 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue0.1Operating income−3.4Net income−7.3EPS, diluted−0.10Fiscal year 2023Operating income−4.0Net income−4.3EPS, diluted−0.07Fiscal year 2024Operating income−28.8Net income−24.7EPS, diluted−2.30Fiscal year 2025Revenue0.0Operating income−4.3Net income−11.8EPS, diluted−0.38
FY2022FY2023FY2024FY2025
Revenue 0.1 n/a n/a 0.0
Growth
Operating income −3.4 −4.0 −28.8 −4.3
Net income −7.3 −4.3 −24.7 −11.8
Growth
EPS, diluted −0.10 −0.07 −2.30 −0.38
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2022Operating margin−6,808.0%Net margin−14,510.0%Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−13,381.3%Net margin−36,993.8%
FY2022FY2023FY2024FY2025
Operating margin −6,808.0% n/a n/a −13,381.3%
Net margin −14,510.0% n/a n/a −36,993.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2022Operating cash flow−2.2Fiscal year 2023Operating cash flow−2.9Fiscal year 2024Operating cash flow−2.9Fiscal year 2025Operating cash flow−1.9
FY2022FY2023FY2024FY2025
Operating cash flow −2.2 −2.9 −2.9 −1.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.0Shareholders’ equity29.6Fiscal year 2023Cash0.0Shareholders’ equity25.2Fiscal year 2024Cash2.0Shareholders’ equity4.3Fiscal year 2025Cash0.0Shareholders’ equity12.6
FY2022FY2023FY2024FY2025
Cash 0.0 0.0 2.0 0.0
Shareholders’ equity 29.6 25.2 4.3 12.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.1 n/a n/a 0.0
Growth
n/a n/a n/a 0.4
1.2 1.7 0.3 0.3
0.3 0.3 0.7 0.9
−3.4 −4.0 −28.8 −4.3
Growth
−7.9 −4.4 −24.7 −14.5
−0.6 n/a 0.0 −2.6
−7.3 −4.3 −24.7 −11.8
Growth
Per share
−0.10 −0.07 −2.30 −0.38
−0.10 −0.07 −2.30 −0.38
Growth
70.5 60.2 10.8 31.6

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.